1. "Gastrointestinal Oncology Service"
Formats
  1. Journal Article (2302)
  2. Meeting Abstract (1841)
  3. Review (139)
  4. Book Section (123)
  5. Editorial (93)
  6. Guidelines (36)
  7. Correspondence (33)
  8. Conference Paper (23)
  9. Miscellaneous (21)
  10. Research Letter (17)
  11. Book Whole (12)
Groups
  1. Gastrointestinal Oncology Service (4640)
  2. Solid Tumor Oncology Division (4640)
  3. Department of Medicine (4638)
  4. Center for Pancreatic Cancer Research (2270)
  5. Surgery (1040)
  6. Survivorship Research (992)

More Groups

People
  1. Leonard Saltz (790)
  2. Eileen O'Reilly (780)
  3. Ghassan Abou-Alfa (568)
  4. Nancy Kemeny (543)
  5. David Kelsen (537)
  6. David Ilson (433)

More People

Years
  1. 2025 (118)
  2. 2024 (307)
  3. 2023 (362)
  4. 2022 (346)
  5. 2021 (345)
  6. 2020 (326)

More Years

Publications
  1. Journal of Clinical Oncology (1276)
  2. Annals of Oncology (320)
  3. Annals of Surgical Oncology (140)
  4. Cancer (127)
  5. Clinical Cancer Research (107)
  6. Cancer Research (94)

More Publications

Publishers
  1. American Society of Clinical Oncology (1355)
  2. Oxford University Press (447)
  3. Elsevier Inc. (404)
  4. Springer (310)
  5. American Association for Cancer Research (279)
  6. Wiley Blackwell (239)

More Publishers

Results (4640)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Experience and impacts of remote telepathology consultation in improving cancer patients' diagnosis and management in China
    Meeting Abstract

    He, G.; Yan, M.; Wu, Q.; Wang, Y.; Zhang, Y.; Lu, J. A.; Wu, J.; Li, X.; Zhao, S.; Gu, P.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Total neoadjuvant chemo (ctx; TNT) for locally advanced gastric cancer (GC): The Memorial Sloan Kettering Cancer Center experience
    Meeting Abstract

    Greally, M.; Strong, V. E.; Yoon, S. S.; Coit, D. G.; Chou, J. F.; Capanu, M.; Kelsen, D. P.; Janjigian, Y. Y.; Ilson, D. H.; Ku, G. Y.
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Clinical and molecular factors predicting resistance to first-line (1L) FOLFOX in patients (pts) with advanced esophagogastric cancer (EGA) and patterns of subsequent therapy
    Meeting Abstract

    Greally, M.; Walch, H. S.; Chou, J. F.; Capanu, M.; Kelsen, D. P.; Ilson, D. H.; Janjigian, Y. Y.; Schultz, N.; Ku, G. Y.
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Advanced cancer patients' changes in terminal illness understanding (TIU) and their psychological well-being
    Meeting Abstract

    George, L. S.; Shen, M. J.; Maciejewski, P. K.; Epstein, A. S.; Prigerson, H. G.
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Frameshift mutations (Fsindel) complement tumor mutation burden (TMB) in predicting survival after immune checkpoint inhibitors (ICI) in a pancancer analysis
    Meeting Abstract

    Florou, V.; Park, W.; Hosein, P. J.; Wilky, B. A.; Trent, J. C.; Lopes, G.
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Factors associated with one-year mortality after debulking surgery in older women with ovarian cancer
    Meeting Abstract

    Filippova, O. T.; Tew, W. P.; O'Cearbhaill, R. E.; Sonoda, Y.; Long-Roche, K. C.; Zivanovic, O.; Gardner, G. J.; Chi, D.; Shahrokni, A.
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Risk stratification and daily symptom monitoring for oncology patients
    Meeting Abstract

    Daly, R. M.; Perry, C.; Chiu, Y. O.; Katzen, L. L.; Rozenshteyn, M.; Kuperman, G.; Dhami, A. K.; Salvaggio, R.; Baldwin, A.; Holland, J. C.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • A framework for building a clinically relevant risk model
    Meeting Abstract

    Daly, R. M.; Gorenshteyn, D.; Gazit, L.; Sokolowski, S.; Nicholas, K.; Perry, C.; Adams, L.; Baldwin, A.; Holland, J. C.; Zervoudakis, A.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Prospective randomized phase II trial of pazopanib versus placebo in patients with progressive carcinoid tumors (CARC) (Alliance A021202)
    Meeting Abstract

    Bergsland, E. K.; Mahoney, M. R.; Asmis, T. R.; Hall, N.; Kumthekar, P.; Maitland, M. L.; Niedzwiecki, D.; Nixon, A. B.; O'Reilly, E. M.; Schwartz, L. H.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Long-term follow-up of CA209-004: A phase I dose-escalation study of combined nivolumab (NIVO) and ipilimumab (IPI) in patients with advanced melanoma
    Meeting Abstract

    Atkins, M. B.; Kirkwood, J. M.; Wolchok, J. D.; Callahan, M. K.; Kluger, H. M.; Postow, M. A.; Segal, N. H.; Lesokhin, A. M.; Balogh, A.; Re, S.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save